Saint Therapeutics Founder and CMO Dr. Chia Soo Speaks on Space Medicine and Regenerative Healing at PSRC 2026

Saint Therapeutics is pleased to share that Chia Soo, MD, FACS, Founder and Chief Medical Officer of Saint Therapeutics, participated in the UCLA Local Program at the Plastic Surgery Research Council Annual Meeting 2026.

Dr. Soo joined the Space and Science Panel, titled “The Final Frontier Meets Humans,” where she discussed her pioneering research in wound healing, tissue regeneration, and the effects of microgravity on biological healing processes. The panel explored how insights from space-related research may contribute to the advancement of regenerative medicine and support the development of new therapeutic approaches for patients on Earth.

As a company focused on translating breakthrough science into innovative therapies, Saint Therapeutics remains committed to advancing solutions that improve healing outcomes and reduce scarring. Dr. Soo’s participation at PSRC 2026 reflects the company’s scientific vision and its ongoing dedication to bridging fundamental research, translational medicine, and clinical innovation.